2.6.1.5 Arthritis, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8906315&form=6&db=m The influence of antagonists of poly(ADP-ribose)polymerase on the activity of antirheumatic drugs on the development of adjuvant arthritis in rats and on the induction of tyrosine aminotransferase in the liver of rats. causal interaction,ongoing research,unassigned 1,4,0 2.6.1.5 Asbestosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6315371&form=6&db=m Biochemical mechanisms in asbestos toxicity. therapeutic application,unassigned 1,0 2.6.1.5 Brain Ischemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23793526&form=6&db=m Analysis of serum metabolites for the discovery of amino acid biomarkers and the effect of galangin on cerebral ischemia. unassigned - 2.6.1.5 Carcinoma 256, Walker http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13705706&form=6&db=m Changes in liver tyrosine-alpha-ketoglutarate transaminase activity during growth of Walker carcinosarcoma 256. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10312&form=6&db=m Synthesis of a liver enzyme in hybrid cells. diagnostic usage,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13795&form=6&db=m Inhibition by ultraviolet irradiation of the glucocorticoid induction of tyrosine aminotransferase in bromodeoxyuridine-treated H-35 hepatoma. therapeutic application,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15997&form=6&db=m Effect of concanavalin A on tyrosine aminotransferase in rat hepatoma tissue culture cells. Rapid reversible inactivation of soluble enzyme. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16019&form=6&db=m The influence of culture conditions on the induction of tyrosine aminotransferase by cyclic nucleotides in rat hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16922&form=6&db=m Interaction of glucocorticoid hormones and cyclic nucleotides in induction of tyrosine aminotransferase in cultured hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17084&form=6&db=m Effect of pyridoxine on the growth of Morris hepatoma No. 7288Ctc and enzyme activity. diagnostic usage,ongoing research,unassigned 1,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17085&form=6&db=m Expression of hormonally induced tyrosine transaminase in normal, host liver and three Morris hepatomas. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18211&form=6&db=m Interconversion of multiple forms of tyrosine aminotransferase in vitro and in vivo in cultured hepatoma cells. diagnostic usage,ongoing research,unassigned 3,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20448&form=6&db=m The stability of tyrosine aminotransferase and other proteins in enucleated rat hepatoma tissue culture cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21184&form=6&db=m Nucleus-dependent regulation of tyrosine aminotransferase degradation in hepatoma tissue culture cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22474&form=6&db=m Establishment of a clonal strain of hepatoma cells derived from Morris hepatoma 8999. ongoing research,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26702&form=6&db=m Relationship between phosphorylation of tyrosine aminotransferase and regulation of its synthesis by cyclic AMP and hormones. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30645&form=6&db=m Regulation of tyrosine aminotransferase synthesis in vitro by mRNA and soluble factors from hepatoma tissue culture cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30646&form=6&db=m Translation of tyrosine aminotransferase mRNA from hepatoma cells in a wheat germ cell-free system. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=36231&form=6&db=m Induction of tyrosine aminotransferase by dibutyryl cyclic-AMP in synchronized hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=36980&form=6&db=m Effects of dietary vitamin B6 on the in vitro inactivation of rat tyrosine aminotransferase in host liver and Morris hepatomas. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,4,4,1 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=40117&form=6&db=m Somatic cell fusion in the study of glucocorticoid action. ongoing research,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=40618&form=6&db=m Variations in some molecular events during the early phases of the reuber H 35 hepatoma cell cycle. I. Glucocorticoid induction of tyrosine aminotransferase. causal interaction,therapeutic application,unassigned 1,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=44296&form=6&db=m Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells. therapeutic application,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=195814&form=6&db=m Activity of protein kinase dependent on adenosine 3':5'-monophosphate and of its thermostable protein inhibitor in rat hepatoma (HTC) cells. Unlikely role in the permissive action of glucocorticoids. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=235557&form=6&db=m Analysis of the induction and deinduction of tyrosine aminotransferase in enucleated HTC cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=236756&form=6&db=m Insulin induction of tyrosine aminotransferase in synchronized hepatoma cells. causal interaction,ongoing research,unassigned 1,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=236835&form=6&db=m "Superinduction" of tyrosine aminotransferase by actinomycin D: a reevaluation. ongoing research,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=237268&form=6&db=m Kinetics of steroid induction and deinduction of tyrosine aminotransferase synthesis in cultured hepatoma cells. causal interaction,diagnostic usage,ongoing research,unassigned 1,3,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=237887&form=6&db=m Effects of 6- and 8-substituted analogs of adenosine 3':5'-monophosphate on phosphoenolpyruvate carboxykinase and tyrosine aminotransferase in hepatoma cell cultures. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=240862&form=6&db=m The effects of metabolic inhibitors on the synthesis of inducible tyrosine aminotransferase in cultured hepatoma cells. causal interaction,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=241864&form=6&db=m Hormonal induction of tyrosine aminotransferase activity in host liver and hepatoma no. 7777 of normal and cofactor-depleted animals. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1347740&form=6&db=m Modulation of glucocorticoid induction of tyrosine aminotransferase gene expression by variations in cell density. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1350762&form=6&db=m Modulation of glucocorticoid induction of stably transfected tyrosine aminotransferase gene constructs involves elements up-stream of the glucocorticoid-responsive element. causal interaction,ongoing research,unassigned 1,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1354612&form=6&db=m Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription. therapeutic application,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1356017&form=6&db=m Modulation of the agonist activity of antisteroids by a novel cis-acting element. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1357784&form=6&db=m Enzyme induction and receptor-binding affinity of steroidal 20-carboxamides in rat hepatoma tissue culture cells. ongoing research,therapeutic application,unassigned 3,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1358029&form=6&db=m Insulin-mediated inhibition of the induction of tyrosine aminotransferase by dexamethasone. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1584217&form=6&db=m Modulation of transcription factor activity by a distant steroid modulatory element. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1679193&form=6&db=m [Differences in expression and functional organization of the rat tyrosine aminotransferase gene in two lines of Morris hepatoma, 8994 and 7777] ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1690087&form=6&db=m Differential effects of N-methyl-N'-nitro-N-nitrosoguanidine on constitutive and hormone-inducible gene expression in rat hepatoma cells. therapeutic application,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1967611&form=6&db=m Expression and amplification of cloned rat liver tyrosine aminotransferase in nonhepatic cells. causal interaction,diagnostic usage,unassigned 1,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1971416&form=6&db=m Interaction of trans-acting factors and re-expression of liver functions in hepatoma hybrid cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1978678&form=6&db=m Effect of phenobarbital on the glucocorticoid receptor in rat hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1979170&form=6&db=m Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat tyrosine aminotransferase promoter in hepatoma cells. ongoing research,therapeutic application,unassigned 3,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1980597&form=6&db=m Cell-cycle regulation of insulin-stimulated tyrosine aminotransferase activity in rat hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1981248&form=6&db=m [Activation of transcription of the tyrosine aminotransferase gene in the rat McA-RN 7777 hepatoma cell line by cycloheximide] diagnostic usage,ongoing research,unassigned 3,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2454399&form=6&db=m Cyclic adenonosine monophosphate does not affect the stability of the messenger ribonucleic acid for tyrosine aminotransferase in cultured hepatoma cells. ongoing research,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2460210&form=6&db=m Glucocorticoid receptors in hepatocellular carcinoma and adjacent liver tissue. diagnostic usage,ongoing research,unassigned 3,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2564808&form=6&db=m Differential modulation of gene induction by glucocorticoids and antiglucocorticoids in rat hepatoma tissue culture cells. ongoing research,unassigned 2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2564809&form=6&db=m Oncogene mediated repression of glucocorticoid hormone response elements and glucocorticoid receptor levels. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2568581&form=6&db=m Differential activity of a tissue-specific extinguisher locus in hepatic and nonhepatic cells. causal interaction,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2574563&form=6&db=m Insulin-mediated regulation of tyrosine aminotransferase in rat hepatoma cells: inhibition of transcription and inhibition of enzyme degradation. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2575700&form=6&db=m Genetic activity of a trans-regulatory locus in hepatoma hybrid cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2860928&form=6&db=m [Hormonal induction of tyrosine aminotransferase and RNA synthesis in the cells of Morris hepatoma strain 7777] causal interaction,diagnostic usage,ongoing research,unassigned 1,1,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2861890&form=6&db=m Effect of potent antiglucocorticoids on dexamethasone induced enzymes in cultured hepatoma and rat liver cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2869787&form=6&db=m The synergistic interaction of hydrocortisone and dibutyryl cyclic AMP during enzyme induction in hybrids between rat C6 glioma cells and FU5AH hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2870917&form=6&db=m Regulation of insulin and insulin-like growth factor (IGF) responsiveness by IGFs in rat hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2871231&form=6&db=m Metabolism and antiproliferative effect of the glucocorticoid antagonist RU38486 in cultured liver and hepatoma cells. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2872199&form=6&db=m Lipid peroxidation and activities of tyrosine aminotransferase and glutamine synthetase in hepatoma and glioma cells grown in bovine colostrum-supplemented medium. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2872215&form=6&db=m Rat hepatoma cell variants resistant to insulin-diphtheria toxin A fragment conjugates. Genetic evidence for the separate pathways for insulin receptor-mediated mitogenic and hormonal stimulation. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2873903&form=6&db=m Inhibition of steroid-inducible tyrosine aminotransferase gene expression by N-methyl-N'-nitro-N-nitrosoguanidine in a rat hepatoma cell line. causal interaction,ongoing research,therapeutic application,unassigned 1,3,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2874483&form=6&db=m Chromosomal assignment and trans regulation of the tyrosine aminotransferase structural gene in hepatoma hybrid cells. diagnostic usage,ongoing research,unassigned 3,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2875214&form=6&db=m Antiglucocorticoid steroids have increased agonist activity in those hepatoma cell lines that are more sensitive to glucocorticoids. ongoing research,unassigned 2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2875868&form=6&db=m Regulation of gene expression in rat hepatocytes and hepatoma cells by insulin: quantitation of messenger ribonucleic acid's coding for tyrosine aminotransferase, tryptophan oxygenase, and phosphoenolpyruvate carboxykinase. diagnostic usage,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2877119&form=6&db=m Analysis of the relation between receptor binding affinity and antagonist efficacy of antiglucocorticoids. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2879246&form=6&db=m In vivo protein-DNA interactions in a glucocorticoid response element require the presence of the hormone. therapeutic application,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2885083&form=6&db=m A new glucocorticoid receptor detected in host rat liver but not in various hepatomas. causal interaction,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2890387&form=6&db=m [Criteria of the sensitivity of Zajdela and Morris hepatoma cells to glucocorticoids] unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2894483&form=6&db=m Ketoconazole inhibition and glucocorticoid action in the human lymphoblastic leukemia cell line CEM-C7. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2894848&form=6&db=m Transcriptional and posttranscriptional regulation of tyrosine aminotransferase by insulin in rat hepatoma cells. diagnostic usage,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2898939&form=6&db=m The induction, desensitization and de-induction of tyrosine aminotransferase by 8-bromo-cyclic AMP in rat hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2899290&form=6&db=m [Regulation of the transcription of the tyrosine aminotransferase gene by glucocorticoids in Morris hepatoma 7777 and 8994 cells] ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2899655&form=6&db=m Inverse correlation between dexamethasone 21-mesylate agonist activity and sensitivity to dexamethasone for induction of tyrosine aminotransferase in rat hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2900679&form=6&db=m Modulation of hormonal induction of tyrosine aminotransferase and glucocorticoid receptors by aflatoxin B1 and sterigmatocystin in Reuber hepatoma cells. causal interaction,ongoing research,unassigned 1,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2901031&form=6&db=m Differential sensitivity of HTC and Fu5-5 cells for induction of tyrosine aminotransferase by 3',5'-cyclic adenosine monophosphate. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2904511&form=6&db=m Description and analysis of differential sensitivity to glucocorticoids in Fao cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2905263&form=6&db=m Increased turnover of the messenger RNA encoding tyrosine aminotransferase can account for the desensitization and de-induction of tyrosine aminotransferase by 8-bromo-cyclic AMP treatment and removal. ongoing research,therapeutic application,unassigned 1,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3486322&form=6&db=m Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle. diagnostic usage,ongoing research,unassigned 2,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4103958&form=6&db=m A histochemical method for the demonstration of tyrosine aminotransferase in tissue culture cells, and studies of this enzyme in hepatoma tissue culture cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4146264&form=6&db=m Regulation of tyrosine aminotransferase in rat liver. XI. Studies on the relationship of enzyme stability to enzyme turnover in cultured hepatoma cells. diagnostic usage,ongoing research,unassigned 3,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4148697&form=6&db=m Further evidence against post-transcriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4148931&form=6&db=m Regulation of phosphoenolpyruvate carboxykinase and tyrosine transaminase in hepatoma cell cultures. 3. Comparative studies in H35, HTC, MH1C1 and RLC cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4151178&form=6&db=m Effect of pyridoxine deficiency on tyrosine transaminase activity and growth of four Morris hepatomas. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4151190&form=6&db=m Aryl hydrocarcon hydroxylase and tyrosine aminotransferase activities in somatic-cell hybrids derived from hepatoma tissue culture HTC (rat) cells and 3T3 (mouse) benzo(a)pyrene-resistant cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4151194&form=6&db=m The role of messenger RNA in tyrosine aminotransferase superinduction: effects of camptothecin on hepatoma cells in culture. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4151862&form=6&db=m Alteration of tyrosine aminotransferase activity in hepatoma cells in tissue culture by amphotericin B. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4152137&form=6&db=m Selectivity of interferon action: hormonal induction of tyrosine aminotransferase in rat hepatoma cells is much less sensitive to interferon than the replication of vesicular stomatitis virus or reovirus. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4153658&form=6&db=m Induction of aryl hydrocarbon (benzo(a)pyrene) hydroxylase and tyrosine aminotransferase in hepatoma cells in culture. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4154198&form=6&db=m Effect of B6 deficiency on hepatoma 7794A growth rate: activities of tyrosine transaminase and serine dehydratase before and after induction by hydrocortisone. causal interaction,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4154871&form=6&db=m Inhibition of steroid inducible tyrosine aminotransferase by mouse and rat interferon in hepatoma tissue culture cells. causal interaction,ongoing research,therapeutic application,unassigned 1,3,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4156383&form=6&db=m The role of transcortin in glucocorticoid mediated enzyme induction: tyrosine aminotransferase induction in hepatoma tissue culture cells. causal interaction,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4315614&form=6&db=m The relationship between glucocorticoid binding and tyrosine aminotransferase induction in hepatoma tissue culture cells. causal interaction,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4323347&form=6&db=m Effects of exogenous histones upon the induction of tryptophan pyrrolase and tyrosine transaminase in liver and Morris hepatomas. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4383907&form=6&db=m Effect of inhibitors of nucleic acid synthesis on steroid-mediated induction of tyrosine aminotransferase in hepatoma cell cultures. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4386986&form=6&db=m "Superinduction" of tyrosine transaminase in hepatoma cell cultures: differential inhibition of synthesis and turnover by actionomycin D. causal interaction,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4388856&form=6&db=m Synthesis and induction of tyrosine aminotransferase in synchronized hepatoma cells in culture. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4390098&form=6&db=m Induction of tyrosine aminotransferase by D-glucosamine in rat hepatoma cell culture. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4391285&form=6&db=m Control of degradation and synthesis of induced tyrosine aminotransferase studied in hepatoma cells in culture. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4392629&form=6&db=m Dexamethasone phosphate-induced synthesis of tyrosine aminotransferase in hepatoma tissue culture cells. Studies of the early phases of induction and of the steroid requirement for maintanance of the induced rate of synthesis. causal interaction,ongoing research,unassigned 1,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4393727&form=6&db=m Amino acid transport in hepatoma cell cultures during tyrosine aminotransferase induction. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4395444&form=6&db=m Superinduction of tyrosine aminotransferase by actinomycin D in rat hepatoma (HTC) cells. ongoing research,unassigned 2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4395684&form=6&db=m Expression of differentiated functions in hepatoma cell hybrids. I. Tyrosine aminotransferase in hepatoma-fibroblast hybrids. ongoing research,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4396794&form=6&db=m Preferential inhibition by 5-bromodeoxyuridine of the synthesis of tyrosine aminotransferase in hepatoma cell cultures. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4397568&form=6&db=m Induction of tyrosine aminotransferase by dibutyryl cyclic-AMP employing hepatoma cells in tissue culture. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4397779&form=6&db=m Tyrosine transaminase induction: differential effect of 5-azacytidine on liver and hepatoma 5123D. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4398132&form=6&db=m Turnover of tyrosine transaminase in cultured hepatoma cells after inhibition of protein synthesis. causal interaction,ongoing research,therapeutic application,unassigned 2,3,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4399292&form=6&db=m Induction of tyrosine aminotransferase and amino acid transport in Morris hepatomas and in adult and neonatal rat liver. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4399619&form=6&db=m Regulation of phosphoenolpyruvate carboxykinase and tyrosine transaminase in hepatoma cell cultures. I. Effects of glucocorticoids, N 6 ,O 2' -dibutyryl cyclic adenosine 3',5'-monophosphate and insulin in Reuber H35 cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4399833&form=6&db=m Expression of differentiated functions in hepatoma cell hybrids: reappearance of tyrosine aminotransferase inducibility after the loss of chromosomes. ongoing research,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4403717&form=6&db=m Effect of cordycepin on induction of tyrosine aminotransferase employing hepatoma cells in tissue culture. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4404031&form=6&db=m Further evidence for posttranscriptional control of inducible tyrosine aminotransferase synthesis in cultured hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4404162&form=6&db=m Naturally occurring and induced levels of amino acid transport and tyrosine aminotransferase in rats bearing Morris hepatomas. ongoing research,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4405028&form=6&db=m Synthesis of inducible tyrosine aminotransferase in a cell-free extract from cultured hepatoma cells. causal interaction,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=5542684&form=6&db=m Studies on the degradation of tyrosine aminotransferase in hepatoma cells in culture. Influence of the composition of the medium and adenosine triphosphate dependence. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6102484&form=6&db=m Studies on the different molecular forms of tyrosine aminotransferase from rat liver and hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6103714&form=6&db=m Regulation of hepatoma tissue culture cell tyrosine aminotransferase messenger ribonucleic acid by dexamethasone. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6106509&form=6&db=m Induction of tyrosine aminotransferase and amino acid transport in rat hepatoma cells by insulin and the insulin-like growth factor, multiplication-stimulating activity. Mediation by insulin and multiplication-stimulating activity receptors. causal interaction,ongoing research,unassigned 1,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6109731&form=6&db=m Tyrosine aminotransferase sensitivity to bromodeoxyuridine during restricted intervals of S phase in hepatoma cells. ongoing research,therapeutic application,unassigned 3,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6110670&form=6&db=m Induction of tyrosine aminotransferase in H-35 hepatoma cells by cAMP captured in phospholipid vesicles. ongoing research,unassigned 2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6112052&form=6&db=m [Use of the tyrosine aminotransferase induction system for the demonstration of the signal effect of glucocorticoid hormones] therapeutic application,unassigned 2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6112172&form=6&db=m A post-transcriptional site of induction of tyrosine aminotransferase by dexamethasone in Reuber H35 hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6112988&form=6&db=m Regulation of expression of tyrosine aminotransferase in somatic cell hybrids between rat hepatoma cells and mouse fibroblasts. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6113176&form=6&db=m Relations between steroid-cell contact, steroid-binding and induction of tyrosine aminotransferase. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6114749&form=6&db=m Further evidence for translational regulation of tyrosine aminotransferase synthesis by dibutyryl cyclic AMP in Reuber H35 hepatoma cells. causal interaction,ongoing research,unassigned 1,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6114952&form=6&db=m Physical properties, limited proteolysis, and acetylation of tyrosine aminotransferase from rat liver. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6114961&form=6&db=m The involvement of cyclic GMP in tyrosine aminotransferase degradation in rat hepatoma tissue culture cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6117128&form=6&db=m Lectins mimic insulin in the induction of tyrosine aminotransferase. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6118363&form=6&db=m Regulation of tyrosine aminotransferase by insulin in cultured rat hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6120038&form=6&db=m Selective effect of the metallocarcinogen beryllium on hormonal regulation of gene expression in cultured cells. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6121706&form=6&db=m Positive and negative cAMP-mediated control of tyrosine aminotransferase synthesis in Reuber H35 hepatoma cells. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6124249&form=6&db=m Inverse correlation between cyclic GMP and tyrosine aminotransferase degradation in rat hepatoma tissue culture cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6126188&form=6&db=m Explanation for the apparent inactivation of tyrosine aminotransferase in hepatoma cells by concanavalin A. causal interaction,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6127118&form=6&db=m Concanavalin A alters the turnover rate of tyrosine aminotransferase in cultured hepatoma cells. causal interaction,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6131694&form=6&db=m Differences in the mode of regulation of ornithine decarboxylase and tyrosine aminotransferase in H-35 rat hepatoma cells shown by varying the medium composition. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6131900&form=6&db=m Direct evidence that the protein kinase catalytic subunit mediates the effects of cAMP on tyrosine aminotransferase synthesis. diagnostic usage,ongoing research,unassigned 3,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6135812&form=6&db=m Induction of tyrosine aminotransferase activity by concanavalin A in cultured rat hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6136964&form=6&db=m Differences in rates of tyrosine aminotransferase deinduction with cyclic AMP and glucocorticoids. causal interaction,ongoing research,unassigned 1,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6137358&form=6&db=m Analysis of insulin action using differentiated and dedifferentiated hepatoma cells. causal interaction,ongoing research,unassigned 2,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6138031&form=6&db=m Glucagon resistance of hepatoma cells. Evidence for receptor and post-receptor defects. diagnostic usage,ongoing research,unassigned 1,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6143573&form=6&db=m Variations in some molecular events during the early phases of the Reuber H35 cell cycle. IV-regulation of tyrosine aminotransferase. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6147198&form=6&db=m A genetic analysis of extinction: trans-dominant loci regulate expression of liver-specific traits in hepatoma hybrid cells. diagnostic usage,ongoing research,unassigned 3,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6149545&form=6&db=m Loss of reciprocal modulations of growth and liver function of hepatoma cells in culture by contact with cells or cell membranes. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6167286&form=6&db=m Inhibition of tyrosine aminotransferase induction by UTP deficiency and its reversal by 5-fluorouridine in cultured hepatoma cells. causal interaction,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6174324&form=6&db=m Selective inhibition by sodium butyrate of glucocorticoid-induced tyrosine aminotransferase synthesis in hepatoma tissue-cultured cells. diagnostic usage,ongoing research,therapeutic application,unassigned 3,4,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6196356&form=6&db=m Pretranslational control of tyrosine aminotransferase synthesis by 8-bromo-cyclic AMP in H-4 rat hepatoma cells. causal interaction,diagnostic usage,ongoing research,unassigned 2,4,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6205913&form=6&db=m Transmembrane delivery of polypeptide hormones bypassing the intrinsic cell surface receptors: a conjugate of insulin with alpha 2-macroglobulin (alpha 2M) recognizing both insulin and alpha 2M receptors and its biological activity in relation to endocytic pathways. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6259447&form=6&db=m On the steroid requirement for induction of tyrosine aminotransferase by N6, O2'-dibutyryl cyclic AMP in hepatoma cells. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6265064&form=6&db=m Regulation of urea cycle enzymes in transplantable hepatomas and in the livers of tumor-bearing rats and humans. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7624883&form=6&db=m The acute effect of lead acetate on glucocorticoid regulation of tyrosine aminotransferase in hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7668545&form=6&db=m Cytokines and the activity of tyrosine aminotransferase and superoxide dismutase in rat hepatoma cells in culture. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7885082&form=6&db=m Normal and stable transfected cancer cell lines: tools for a screening of progestogenic, antiprogestogenic and antiglucocorticoid substances. diagnostic usage,ongoing research,unassigned 3,2,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8095029&form=6&db=m Epidermal growth factor inhibits phosphoenolpyruvate carboxykinase gene expression in rat hepatocytes in primary culture. diagnostic usage,ongoing research,unassigned 3,3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8101632&form=6&db=m The distal enhancer implicated in the developmental regulation of the tyrosine aminotransferase gene is bound by liver-specific and ubiquitous factors. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8123592&form=6&db=m Constancy of expression of the protein kinase A regulatory subunit R1 alpha in hepatoma cell lines of different phenotypes. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9128187&form=6&db=m Lead may affect glucocorticoid signal transduction in cultured hepatoma cells through inhibition of protein kinase C. causal interaction,ongoing research,therapeutic application,unassigned 4,4,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9837781&form=6&db=m Rat primary hepatocytes and H4 hepatoma cells display differential sensitivity to cyclic AMP at the level of expression of tyrosine aminotransferase. diagnostic usage,ongoing research,unassigned 3,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10713309&form=6&db=m New steroidal anti-inflammatory antedrugs: methyl 21-desoxy-21-chloro-11beta,17alpha-dihydroxy-3,20-dioxo-1, 4-pregnadiene-16alpha-carboxylate, methyl 21-desoxy-21-chloro-11beta-hydroxy-3,20-dioxo-1, 4-pregnadiene-16alpha-carboxylate, and their 9alpha-fluoro derivatives*. diagnostic usage,ongoing research,unassigned 2,4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10903220&form=6&db=m Transcriptional potencies of inhaled glucocorticoids. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11322967&form=6&db=m Correlation between different gene expression assays designed to measure trans-activation potencies of systemic glucocorticoids. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12016972&form=6&db=m [Effects of oxidative stress on the proliferation, differentiation and apoptosis in the human hepatoma cells] causal interaction,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12188035&form=6&db=m Species-specific differences in the glucocorticoid receptor transactivation function upon binding with betamethasone-esters. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15035826&form=6&db=m Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+. causal interaction,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15044432&form=6&db=m 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. unassigned - 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15310238&form=6&db=m Arsenic at very low concentrations alters glucocorticoid receptor (GR)-mediated gene activation but not GR-mediated gene repression: complex dose-response effects are closely correlated with levels of activated GR and require a functional GR DNA binding domain. ongoing research,therapeutic application,unassigned 3,1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15755314&form=6&db=m Xenobiotics and the glucocorticoid receptor: additive antagonistic effects on tyrosine aminotransferase activity in rat hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18304804&form=6&db=m Differential recruitment of glucocorticoid receptor phospho-isoforms to glucocorticoid-induced genes. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20209601&form=6&db=m Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma. causal interaction,unassigned 1,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22359001&form=6&db=m Stimulation of liver functions in hierarchical co-culture of bone marrow cells and hepatocytes. ongoing research,unassigned 3,0 2.6.1.5 Carcinoma, Hepatocellular http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32542016&form=6&db=m Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,4,0 2.6.1.5 Carcinosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=13705706&form=6&db=m Changes in liver tyrosine-alpha-ketoglutarate transaminase activity during growth of Walker carcinosarcoma 256. ongoing research,unassigned 3,0 2.6.1.5 Chagas Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17678649&form=6&db=m Trypanosoma cruzi: characterisation of the gene encoding tyrosine aminotransferase in benznidazole-resistant and susceptible populations. causal interaction,unassigned 1,0 2.6.1.5 Cholera http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1690715&form=6&db=m Cyclic AMP responses are suppressed in mammalian cells expressing the yeast low Km cAMP-phosphodiesterase gene. diagnostic usage,ongoing research,unassigned 3,4,0 2.6.1.5 Craniopharyngioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2797392&form=6&db=m Steroid hormone receptors in meningiomas of Chinese patients. diagnostic usage,unassigned 3,0 2.6.1.5 Cystinosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Darier Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Diabetes Mellitus http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30121910&form=6&db=m Effects Mifepristone on Aminotransferase Activities in the Liver in Rats with Streptozotocin-Induced Diabetes Mellitus. ongoing research,unassigned 3,0 2.6.1.5 Diabetes Mellitus, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16387&form=6&db=m [Activity and isoenzymes of tyrosine-alpha-ketoglutarate transaminase in the liver cytostructures of rats with alloxan diabetes. Effect of insulin] ongoing research,unassigned 2,0 2.6.1.5 Diabetes Mellitus, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4385011&form=6&db=m Modification of the pyridoxine-induction of tyrosine transaminase in rat liver by thyroid hormones and by alloxan diabetes. ongoing research,unassigned 1,0 2.6.1.5 Fabry Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Genetic Diseases, Inborn http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31705440&form=6&db=m Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats. causal interaction,unassigned 4,0 2.6.1.5 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2869787&form=6&db=m The synergistic interaction of hydrocortisone and dibutyryl cyclic AMP during enzyme induction in hybrids between rat C6 glioma cells and FU5AH hepatoma cells. ongoing research,unassigned 4,0 2.6.1.5 Glioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2872199&form=6&db=m Lipid peroxidation and activities of tyrosine aminotransferase and glutamine synthetase in hepatoma and glioma cells grown in bovine colostrum-supplemented medium. ongoing research,unassigned 3,0 2.6.1.5 Hemangioblastoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2797392&form=6&db=m Steroid hormone receptors in meningiomas of Chinese patients. diagnostic usage,unassigned 3,0 2.6.1.5 Hepatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=43646&form=6&db=m Induction of tyrosine aminotransferase in galactosamine hepatitis. causal interaction,unassigned 2,0 2.6.1.5 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19118596&form=6&db=m Reversible hyperglycemia in rats following acute exposure to acephate, an organophosphorus insecticide: role of gluconeogenesis. causal interaction,unassigned 4,0 2.6.1.5 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22305719&form=6&db=m Insights into the mechanisms mediating hyperglycemic and stressogenic outcomes in rats treated with monocrotophos, an organophosphorus insecticide. unassigned - 2.6.1.5 Hyperglycemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30916837&form=6&db=m Resistance training restores metabolic alterations induced by monosodium glutamate in a sex-dependent manner in male and female rats. causal interaction,unassigned 2,0 2.6.1.5 Hypokinesia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11540060&form=6&db=m The effect of space flight on the board of the satellite Cosmos 2044 on plasma hormone levels and liver enzyme activities of rats. unassigned - 2.6.1.5 Ichthyosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=45516&form=6&db=m Effects of Schistosoma mansoni and Schistosoma japonicum infections on induction of hepatic tyrosine aminotransferase in mice. ongoing research,unassigned 4,0 2.6.1.5 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1319348&form=6&db=m The hepatocyte-specific phenotype of murine liver cells correlates with high expression of connexin32 and connexin26 but very low expression of connexin43. unassigned - 2.6.1.5 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2846579&form=6&db=m Hormonal regulation of chimeric genes containing the phosphoenolpyruvate carboxykinase promoter regulatory region in hepatoma cells infected by murine retroviruses. ongoing research,unassigned 3,0 2.6.1.5 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7037281&form=6&db=m Phenylalanine metabolism in Microtus montanus chronically infected with Trypanosoma brucei gambiense. diagnostic usage,unassigned 1,0 2.6.1.5 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9451863&form=6&db=m Diagnosis of chronic camel trypanosomosis by detection of the antibody of trypanosome tyrosine aminotransferase. diagnostic usage,ongoing research,unassigned 1,2,0 2.6.1.5 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9645841&form=6&db=m Increased excretion of aromatic amino acid catabolites in animals infected with Trypanosoma brucei evansi. diagnostic usage,unassigned 1,0 2.6.1.5 Infections http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9920321&form=6&db=m Diagnosis of trypanosomiasis in experimental mice and field-infected camels by detection of antibody to trypanosome tyrosine aminotransferase. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,3,1 2.6.1.5 Intellectual Disability http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23331&form=6&db=m Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome). causal interaction,unassigned 4,0 2.6.1.5 Intellectual Disability http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16917729&form=6&db=m TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping. causal interaction,unassigned 4,0 2.6.1.5 Intellectual Disability http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28255985&form=6&db=m Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation. causal interaction,unassigned 4,0 2.6.1.5 Keratitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23331&form=6&db=m Molecular biology and molecular pathology of a newly described molecular disease--tyrosinemia II (the Richner-Hanhart syndrome). causal interaction,unassigned 4,0 2.6.1.5 Keratitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16917729&form=6&db=m TAT gene mutation analysis in three Palestinian kindreds with oculocutaneous tyrosinaemia type II; characterization of a silent exonic transversion that causes complete missplicing by exon 11 skipping. causal interaction,unassigned 4,0 2.6.1.5 Keratoderma, Palmoplantar http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6124575&form=6&db=m Richner-Hanhart's syndrome: ultrastructural abnormalities of epidermal keratinization indicating a causal relationship to high intracellular tyrosine levels. unassigned - 2.6.1.5 Lipidoses http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Liver Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2872762&form=6&db=m [The glucocorticoid receptors and the induction of tyrosine aminotransferase by glucocorticoid in the human liver cancer cell line (SMMC-7721) in vitro] ongoing research,unassigned 3,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26038&form=6&db=m Expression of hormonally induced tyrosine aminotransferase in host liver and Morris hepatoma No. 7777 during cofactor depletion. ongoing research,unassigned 3,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31284&form=6&db=m Messenger RNA activities for two liver enzymes, tyrosine aminotransferase and tryptophan oxygenase, in Morris hepatoma 5123C and 9618A and in HTC cells. Correlation with enzyme activities. ongoing research,unassigned 2,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1679193&form=6&db=m [Differences in expression and functional organization of the rat tyrosine aminotransferase gene in two lines of Morris hepatoma, 8994 and 7777] ongoing research,unassigned 4,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2860928&form=6&db=m [Hormonal induction of tyrosine aminotransferase and RNA synthesis in the cells of Morris hepatoma strain 7777] causal interaction,diagnostic usage,ongoing research,unassigned 1,1,3,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2890387&form=6&db=m [Criteria of the sensitivity of Zajdela and Morris hepatoma cells to glucocorticoids] unassigned - 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2899290&form=6&db=m [Regulation of the transcription of the tyrosine aminotransferase gene by glucocorticoids in Morris hepatoma 7777 and 8994 cells] ongoing research,unassigned 4,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4398643&form=6&db=m Further studies on the induction of tyrosine aminotransferase in Morris hepatoma 9618A. ongoing research,unassigned 3,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6140959&form=6&db=m [Biochemical criteria of mammalian cell sensitivity to glucocorticoids] ongoing research,unassigned 3,0 2.6.1.5 Liver Neoplasms, Experimental http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6149545&form=6&db=m Loss of reciprocal modulations of growth and liver function of hepatoma cells in culture by contact with cells or cell membranes. ongoing research,unassigned 4,0 2.6.1.5 Lung Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15531725&form=6&db=m Analysis of co-factor function in a glucocorticoid-resistant small cell carcinoma cell line. ongoing research,unassigned 3,0 2.6.1.5 Lysosomal Storage Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Maple Syrup Urine Disease http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6101930&form=6&db=m The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease. causal interaction,therapeutic application,unassigned 2,2,0 2.6.1.5 Melanoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25309&form=6&db=m Tyrosine aminotransferase in AKR/J albino and C57BL/6J black mouse skin. causal interaction,unassigned 1,0 2.6.1.5 Meningioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2797392&form=6&db=m Steroid hormone receptors in meningiomas of Chinese patients. diagnostic usage,unassigned 3,0 2.6.1.5 Meningioma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8587697&form=6&db=m Progesterone and glucocorticoid receptor activation in meningiomas. ongoing research,unassigned 2,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17084&form=6&db=m Effect of pyridoxine on the growth of Morris hepatoma No. 7288Ctc and enzyme activity. diagnostic usage,ongoing research,unassigned 1,2,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=39858&form=6&db=m Unlinked control of multiple glucocorticoid-induced processes in HTC cells. ongoing research,therapeutic application,unassigned 3,1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=234792&form=6&db=m Induction of enzymes by glucagon, glucose repression, adenosine 3',5'-monophosphate concentration during carcinogenesis and in Morris 6918A hepatoma. diagnostic usage,ongoing research,unassigned 1,1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=241680&form=6&db=m Induction of ornithine decarboxylase, tyrosine aminotransferase, and thymidine kinase by glucocorticoid in isolated, perfused liver after tumor inoculation. causal interaction,diagnostic usage,ongoing research,therapeutic application 3,1,3,1 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1683563&form=6&db=m Chromatin structure of hormono-dependent promoters. therapeutic application,unassigned 1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1683564&form=6&db=m The mechanism for glucocorticoid-resistance in a rat hepatoma cell variant that contains functional glucocorticoid receptor. ongoing research,therapeutic application,unassigned 1,1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1970570&form=6&db=m A glucocorticoid-resistant rat hepatoma cell variant contains functional glucocorticoid receptor. ongoing research,therapeutic application,unassigned 2,1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1979170&form=6&db=m Glucocorticoids locally disrupt an array of positioned nucleosomes on the rat tyrosine aminotransferase promoter in hepatoma cells. ongoing research,therapeutic application,unassigned 3,2,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2436615&form=6&db=m The expressions of oncogenes and liver-specific genes in Morris hepatomas. unassigned - 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2470526&form=6&db=m Transformation of cultured fetal rat liver cells by MDAB and phenobarbital. Morphological, biochemical and immunocytochemical characterization of cell lines. causal interaction,diagnostic usage,ongoing research,unassigned 3,3,3,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2547771&form=6&db=m The mechanism of cAMP-induced glucocorticoid receptor expression. Correlation to cellular glucocorticoid response. unassigned - 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2661921&form=6&db=m DNA regulatory elements for steroid hormones. ongoing research,unassigned 4,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2864925&form=6&db=m Phorbol ester inhibition of hormonal induction of tyrosine aminotransferase. therapeutic application,unassigned 1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2874812&form=6&db=m Effects of an antitumoural rhodium complex on thioacetamide-induced liver tumor in rats. Changes in the activities of ornithine decarboxylase, tyrosine aminotransferase and of enzymes involved in fatty acid and glycerolipid synthesis. ongoing research,unassigned 3,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4145869&form=6&db=m Control of -aminolevulinic acid synthetase and tyrosine aminotransferase in tumors and livers of tumor-bearing rats. ongoing research,unassigned 2,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6113896&form=6&db=m Phorbol myristate acetate (PMA) fails to prevent the appearance of markers associated with muscle and liver differentiation in culture. ongoing research,unassigned 2,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6125259&form=6&db=m Vitamin B6 metabolism in liver and liver-derived tumors. diagnostic usage,unassigned 4,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6135149&form=6&db=m Analysis of glucocorticoid-inducible genes in wild-type and variant rat hepatoma cells. ongoing research,unassigned 3,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6149545&form=6&db=m Loss of reciprocal modulations of growth and liver function of hepatoma cells in culture by contact with cells or cell membranes. ongoing research,unassigned 4,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7789609&form=6&db=m Quantitative differences in androgen and glucocorticoid receptor DNA binding properties contribute to receptor-selective transcriptional regulation. ongoing research,unassigned 3,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8446105&form=6&db=m Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. therapeutic application,unassigned 1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9013763&form=6&db=m Mutant and wild-type androgen receptors exhibit cross-talk on androgen-, glucocorticoid-, and progesterone-mediated transcription. ongoing research,therapeutic application,unassigned 4,1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9828081&form=6&db=m Apoptosis, redifferentiation and arresting proliferation simultaneously triggered by oxidative stress in human hepatoma cells. diagnostic usage,therapeutic application,unassigned 1,1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=10343290&form=6&db=m Selective activation of the probasin androgen-responsive region by steroid hormones. therapeutic application,unassigned 1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=12040020&form=6&db=m Activity of the GR in G2 and mitosis. ongoing research,therapeutic application,unassigned 4,1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=14766007&form=6&db=m Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis. causal interaction,unassigned 3,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15035826&form=6&db=m Dose-dependent regulation of superoxide anion on the proliferation, differentiation, apoptosis and necrosis of human hepatoma cells: the role of intracellular Ca 2+. causal interaction,unassigned 1,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15152571&form=6&db=m [Different responses of DD/He and CC57BR/Mv mice to fasting] unassigned - 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16388947&form=6&db=m Transfection with steroid-responsive reporter constructs shows glucocorticoid rather than androgen responsiveness in cultured Sertoli cells. ongoing research,unassigned 2,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20429289&form=6&db=m [Effect of hepatocarcinogenicity of estragole on the glucocorticoid-mediated induction of liver-specific enzymes and the activity of the transcription factors FOXA and HNF4 in the liver of mouse and rat] causal interaction,unassigned 3,0 2.6.1.5 Neoplasms http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25961197&form=6&db=m Effect of trenbolone acetate plus estradiol on transcriptional regulation of metabolism pathways in bovine liver. causal interaction,ongoing research,unassigned 1,3,0 2.6.1.5 Neurologic Manifestations http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28255985&form=6&db=m Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation. causal interaction,unassigned 4,0 2.6.1.5 Osteosarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2861136&form=6&db=m Shift of circadian metabolic rhythm in BFO osteosarcoma-bearing mice. causal interaction,ongoing research,unassigned 2,3,0 2.6.1.5 Otitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6107239&form=6&db=m The in vivo glucocorticoid and antiglucocorticoid actions of medroxyprogesterone acetate. ongoing research,unassigned 4,0 2.6.1.5 Paraproteinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Parasitemia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9920321&form=6&db=m Diagnosis of trypanosomiasis in experimental mice and field-infected camels by detection of antibody to trypanosome tyrosine aminotransferase. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,3,1 2.6.1.5 Phenylketonurias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6101930&form=6&db=m The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease. causal interaction,therapeutic application,unassigned 2,2,0 2.6.1.5 Photophobia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21145993&form=6&db=m Tyrosinemia type II (Richner-Hanhart syndrome): A new mutation in the TAT gene. causal interaction,ongoing research,unassigned 1,3,0 2.6.1.5 Porphyrias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4396244&form=6&db=m Tryptophan pyrrolase, tryptophan and tyrosine transaminase changes during allylisopropylacetamide-induced porphyria in the rat. ongoing research,unassigned 1,0 2.6.1.5 Porphyrias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4397734&form=6&db=m Glucose effect on tryptophan oxygenase and tyrosine aminotransferase induction after allylisopropylacetamide-induced porphyria in the rat. ongoing research,unassigned 2,0 2.6.1.5 Sarcoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2661921&form=6&db=m DNA regulatory elements for steroid hormones. ongoing research,unassigned 4,0 2.6.1.5 Sarcoma, Yoshida http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4404223&form=6&db=m Hormonal effect on tyrosine aminotransferase activities in Yoshida sarcoma and its variant lines. ongoing research,unassigned 4,0 2.6.1.5 Schistosomiasis japonica http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=45516&form=6&db=m Effects of Schistosoma mansoni and Schistosoma japonicum infections on induction of hepatic tyrosine aminotransferase in mice. ongoing research,unassigned 4,0 2.6.1.5 Sepsis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4386778&form=6&db=m Endocrine influences on altered hepatic tyrosine transaminase activity during pneumococcal septicemia in the rat. ongoing research,unassigned 3,0 2.6.1.5 Skin Diseases http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=35373&form=6&db=m Loss of adaptive mechanisms during aging. causal interaction,ongoing research,unassigned 1,3,0 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=45525&form=6&db=m Effect of nutritional factors and cortisol on tyrosine aminotransferase activity in liver of brook trout, Salvelinus fontinalis Mitchill. unassigned - 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2885871&form=6&db=m Correlation of circadian changes in tyrosine aminotransferase and tryptophan-2-3-dioxygenase in rat liver to irradiation at different times of the day. diagnostic usage,ongoing research,unassigned 2,1,0 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6101541&form=6&db=m Diurnal variations in response of rat liver tyrosine aminotransferase activity to food intake. unassigned - 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6131697&form=6&db=m Regulation of hepatic tyrosine aminotransferase in genetically obese rats. unassigned - 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6477476&form=6&db=m The influence of starvation and tryptophan administration on the metabolism of phenylalanine, tyrosine and tryptophan in isolated rat liver cells. unassigned - 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7077424&form=6&db=m Changes in liver lobule glycogen zonation during prolonged fasting of rats previously fed a 30% casein diet and adapted to a controlled feeding schedule. unassigned - 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8629317&form=6&db=m [The effect of prolonged starvation on changes in the activity of selected adaptive enzymes in rat liver] causal interaction,therapeutic application,unassigned 1,1,0 2.6.1.5 Starvation http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=18030681&form=6&db=m Serine dehydratase and tyrosine aminotransferase activities increased by long-term starvation and recovery by refeeding in rainbow trout (Oncorhynchus mykiss). causal interaction,diagnostic usage,ongoing research,unassigned 1,2,2,0 2.6.1.5 Teratocarcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=44296&form=6&db=m Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells. therapeutic application,unassigned 1,0 2.6.1.5 Trypanosomiasis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9920321&form=6&db=m Diagnosis of trypanosomiasis in experimental mice and field-infected camels by detection of antibody to trypanosome tyrosine aminotransferase. causal interaction,diagnostic usage,ongoing research,therapeutic application 1,2,3,1 2.6.1.5 Typhoid Fever http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=3021&form=6&db=m [The effect of lipids from typhoid endotoxin on the activity of some liver enzymes] unassigned - 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=925342&form=6&db=m Response of the lysosomal system of the corneal epithelium to tyrosine-induced cell injury. causal interaction,unassigned 4,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1356171&form=6&db=m Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus. causal interaction,unassigned 4,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4401188&form=6&db=m Soluble tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers. unassigned - 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4405100&form=6&db=m The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency. unassigned - 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6117279&form=6&db=m Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II. ongoing research,therapeutic application,unassigned 3,1,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7648039&form=6&db=m Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review. causal interaction,unassigned 4,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24961569&form=6&db=m Creatine and Pyruvate Prevent the Alterations Caused by Tyrosine on Parameters of Oxidative Stress and Enzyme Activities of Phosphoryltransfer Network in Cerebral Cortex of Wistar Rats. causal interaction,unassigned 4,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27832414&form=6&db=m Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome. causal interaction,unassigned 3,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28547180&form=6&db=m Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II. causal interaction,unassigned 4,0 2.6.1.5 tyrosine transaminase deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31828693&form=6&db=m Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine. causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=487250&form=6&db=m A syndrome of hereditary tyrosinemia in mink (Mustela vison Schreb.). causal interaction,unassigned 1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=925342&form=6&db=m Response of the lysosomal system of the corneal epithelium to tyrosine-induced cell injury. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1356171&form=6&db=m Hereditary tyrosinaemia type II in a consanguineous Ashkenazi Jewish family: intrafamilial variation in phenotype; absence of parental phenotype effects on the fetus. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1357201&form=6&db=m [The metabolic basis of the hyperphenylalaninemias and tyrosinemia] ongoing research,unassigned 2,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=1357662&form=6&db=m Point mutations in the tyrosine aminotransferase gene in tyrosinemia type II. causal interaction,therapeutic application,unassigned 3,1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2456982&form=6&db=m The human tyrosine aminotransferase gene: characterization of restriction fragment length polymorphisms and haplotype analysis in a family with tyrosinemia type II. causal interaction,diagnostic usage,ongoing research,unassigned 4,3,4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2876972&form=6&db=m New forms of hereditary tyrosinemia type II in mink: hepatic tyrosine aminotransferase defect. therapeutic application,unassigned 1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=2891604&form=6&db=m Inherited and de novo deletion of the tyrosine aminotransferase gene locus at 16q22.1----q22.3 in a patient with tyrosinemia type II. causal interaction,ongoing research,unassigned 4,2,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4389443&form=6&db=m Soluble and mitochondrial forms of tyrosine aminotransferase. Relationship to human tyrosinemia. diagnostic usage,ongoing research,unassigned 3,4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4401188&form=6&db=m Soluble tyrosine aminotransferase deficiency: an unusual cause of corneal ulcers. unassigned - 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4405100&form=6&db=m The origin of urinary p-hydroxyphenylpyruvate in a patient with hepatic cytosol tyrosine aminotransferase deficiency. unassigned - 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6106182&form=6&db=m Defect in soluble tyrosine aminotransferase in skin fibroblasts of a patient with tyrosinemia. unassigned - 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6112939&form=6&db=m [Oculo-cutaneous tyrosinosis (Richner-Hanhart syndrome). Histo-pathological study of a case] ongoing research,unassigned 2,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6117279&form=6&db=m Tyrosine aminotransferase deficiency in mink (Mustela vision): a model for human tyrosinemia II. ongoing research,therapeutic application,unassigned 3,1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6119273&form=6&db=m Metabolic basis of hypertyrosinemia in liver disease. causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6145143&form=6&db=m Enzyme defect in a case of tyrosinemia type I, acute form. ongoing research,unassigned 1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6147810&form=6&db=m Persistent tyrosinemia associated with low activity of tyrosine aminotransferase. causal interaction,diagnostic usage,unassigned 3,2,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6149527&form=6&db=m Tyrosinemia II: lessons in molecular pathophysiology. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7648039&form=6&db=m Richner-Hanhart syndrome (tyrosinemia type II). Case report and literature review. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=7844676&form=6&db=m Painful keratoderma and photophobia: hallmarks of tyrosinemia type II. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8260211&form=6&db=m [A case of tyrosinemia type II with convulsion and EEG abnormality] diagnostic usage,ongoing research,unassigned 1,3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=8975769&form=6&db=m Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat. unassigned - 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9544843&form=6&db=m Novel and recurrent tyrosine aminotransferase gene mutations in tyrosinemia type II. causal interaction,ongoing research,unassigned 3,1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=9630461&form=6&db=m The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat. unassigned - 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15817712&form=6&db=m Comparison of the tyrosine aminotransferase cDNA and genomic DNA sequences of normal mink and mink affected with tyrosinemia type II. causal interaction,ongoing research,unassigned 4,1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16050420&form=6&db=m [Tyrosinemia type II. Case report] causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16318910&form=6&db=m Richner-Hanhart syndrome: report of a case with a novel mutation of tyrosine aminotransferase. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16602095&form=6&db=m The genetic tyrosinemias. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16640556&form=6&db=m The narrow substrate specificity of human tyrosine aminotransferase--the enzyme deficient in tyrosinemia type II. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16863017&form=6&db=m Corneal lesion as the initial manifestation of tyrosinemia type II. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=16902803&form=6&db=m Hepatotoxin-induced hypertyrosinemia and its toxicological significance. unassigned - 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19236704&form=6&db=m Corneal dystrophies. causal interaction,unassigned 2,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19688254&form=6&db=m Tyrosine administration decreases glutathione and stimulates lipid and protein oxidation in rat cerebral cortex. causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21145993&form=6&db=m Tyrosinemia type II (Richner-Hanhart syndrome): A new mutation in the TAT gene. causal interaction,ongoing research,unassigned 1,3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22311600&form=6&db=m Tyrosine impairs enzymes of energy metabolism in cerebral cortex of rats. causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22389994&form=6&db=m Richner-Hanhart syndrome (tyrosinemia type II): a case report of delayed diagnosis with pseudodendritic corneal lesion. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23602810&form=6&db=m Acute administration of l-tyrosine alters energetic metabolism of hippocampus and striatum of infant rats. causal interaction,ongoing research,unassigned 3,1,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24135880&form=6&db=m Effect of acute administration of L-tyrosine on oxidative stress parameters in brain of young rats. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24297753&form=6&db=m L-tyrosine induces DNA damage in brain and blood of rats. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24961569&form=6&db=m Creatine and Pyruvate Prevent the Alterations Caused by Tyrosine on Parameters of Oxidative Stress and Enzyme Activities of Phosphoryltransfer Network in Cerebral Cortex of Wistar Rats. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27285949&form=6&db=m Tyrosinemia type II: Novel mutations in TAT in a boy with unusual presentation. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27832414&form=6&db=m Herpetiform keratitis and palmoplantar hyperkeratosis: warning signs for Richner-Hanhart syndrome. causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=27924409&form=6&db=m Antioxidants reverse the changes in energy metabolism of rat brain after chronic administration of L.-tyrosine. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28255985&form=6&db=m Tyrosinemia type II: Mutation update, 11 novel mutations and description of 5 independent subjects with a novel founder mutation. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28315992&form=6&db=m Omega-3 fatty acid supplementation decreases DNA damage in brain of rats subjected to a chemically induced chronic model of Tyrosinemia type II. causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28547180&form=6&db=m Role of antioxidant treatment on DNA and lipid damage in the brain of rats subjected to a chemically induced chronic model of tyrosinemia type II. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29417439&form=6&db=m Antioxidants Reverse the Changes in the Cholinergic System Caused by L-Tyrosine Administration in Rats. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30949952&form=6&db=m Omega-3 fatty acid supplementation can prevent changes in mitochondrial energy metabolism and oxidative stress caused by chronic administration of L-tyrosine in the brain of rats. causal interaction,unassigned 3,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31705440&form=6&db=m Evidence of hippocampal astrogliosis and antioxidant imbalance after L-tyrosine chronic administration in rats. causal interaction,unassigned 4,0 2.6.1.5 Tyrosinemias http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31828693&form=6&db=m Effects of omega-3 fatty acids supplementation on inflammatory parameters after chronic administration of L-tyrosine. causal interaction,unassigned 3,0 2.6.1.5 Uremia http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4150471&form=6&db=m Translocation of inducible tyrosine aminotransferase to the mitochondrial fraction. Facilitation by acute uremia and other conditions. unassigned - 2.6.1.5 Vesicular Stomatitis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4152137&form=6&db=m Selectivity of interferon action: hormonal induction of tyrosine aminotransferase in rat hepatoma cells is much less sensitive to interferon than the replication of vesicular stomatitis virus or reovirus. unassigned - 2.6.1.5 Vitamin B 12 Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17761010&form=6&db=m Vitamin B12 deficiency results in the abnormal regulation of serine dehydratase and tyrosine aminotransferase activities correlated with impairment of the adenylyl cyclase system in rat liver. causal interaction,unassigned 4,0 2.6.1.5 Vitamin B 6 Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=17609&form=6&db=m Role of coenzyme in aminotransferase turnover. ongoing research,unassigned 2,0 2.6.1.5 Vitamin B 6 Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4151178&form=6&db=m Effect of pyridoxine deficiency on tyrosine transaminase activity and growth of four Morris hepatomas. ongoing research,unassigned 4,0 2.6.1.5 Vitamin B 6 Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=4402387&form=6&db=m The effect of pyridoxine deficiency on L-aromatic amino acid decarboxylase and tyrosine aminotransferase in developing brain. diagnostic usage,ongoing research,unassigned 1,3,0 2.6.1.5 Vitamin B 6 Deficiency http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=6133563&form=6&db=m Pyridoxal 5' phosphate involvement in age-related modifications of tyrosine aminotransferase: multiple form patterns. unassigned -